Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervical Pessary vs. Vaginal Progesterone for Preterm Birth
NCT02470676Phase 3Unknown
- Sponsor
- Hillel Yaffe Medical Center
- Start
- Jul 2015
- Primary completion
- Jul 2018
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Hillel Yaffe Medical Center. Primary endpoints: Preterm birth before 34 weeks of gestation rate in singleton pregnancies and Preterm birth before 32 weeks of gestation rate in twin pregnancies. Status: unknown.
Beyond the preview
Go deeper on NCT02470676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470676.